MSME (Udyam registered) Ministry of MSME
- Category
- Small (2020-21)
- Udyam number
- UDYAM-TS-02-0018395
Pegasus Farmaco (India) Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2021
₹33.13 Cr
▼ 34% YoY
Net profit · FY 2021
₹51.18 Lakh
Net margin 1.5%
EBITDA · FY 2021
₹3.93 Cr
EBITDA margin 11.8%
Authorised capital
₹7.65 Cr
Registered with MCA
Paid-up capital
₹4.47 Cr
Issued & subscribed
Open charges
₹18.06 Cr
Satisfied ₹14.79 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
127
Provident fund records
About Pegasus Farmaco (India) Private Limited
Data last updated:
Pegasus Farmaco (India) Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 October 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1995PTC022036. Its GSTIN is 36AABCP2118E1ZW (Telangana). The company holds 6 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹7.65 Cr and a paid-up capital of ₹4.47 Cr. It is led by directors Raghuveer Beti (Managing Director) and Neeraja Beti.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 1 – 3 – 183/40/B/1 S.B.I Colonygandhi Nagar Hyderabad – 500 080., Telangana, India – 500080.
As per the financials filed for FY 2021, the company reported a revenue of ₹33.13 Cr, a decline of 34% compared to the previous year. For the same year it recorded a net profit of ₹51.18 Lakh (net margin 1.5%) and EBITDA of ₹3.93 Cr (EBITDA margin 11.8%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 13% over five years.
The company has about 127 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Pegasus Farmaco. As per MCA filings, the company has open charges of ₹18.06 Cr and satisfied charges of ₹14.79 Cr on record. Court records list 38 cases involving the company, including 3 filed by the company and 35 filed against it; 19 cases are pending. The company has 7 deals on record (3 funding rounds, 2 rights issues, 2 secondary share transfers), with disclosed funding of ₹3.35 Cr; the latest was in January 2019. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Kosher Pharmaceutical Private Limited with revenue of ₹33.59 Cr.
Pegasus Farmaco (India) Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0018395). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pegasusfarmaco.com.
Company details
CIN U24230TG1995PTC022036
Registration Number 022036
Incorporation Date 18 October 1995
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 November 2021
Date of Balance Sheet 31 March 2021
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0018395
CIN history
Pegasus Farmaco (India) has one previous CIN (Corporate Identification Number): U24230AP1995PTC022036. The current CIN is U24230TG1995PTC022036, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG1995PTC022036 | Current |
| U24230AP1995PTC022036 | Previous |
Recognitions & Rankings of Pegasus Farmaco (India)
Contact details
Pegasus Farmaco (India) Private Limited's registered office is in Hyderabad, Telangana. Its website is pegasusfarmaco.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered Address1 – 3 – 183/40/B/1 S.B.I Colonygandhi Nagar Hyderabad – 500 080., Telangana, India – 500080
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pegasus Farmaco (India) Private Limited, buy the company report.
Comprehensive company report
Pegasus Farmaco (India) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Pegasus Farmaco (India) operates one associated brand: Pegasus Farmaco. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of capsules, tablets, syrups, drops, ointments and injectables | pegasusfarmaco.com |
Business activity
The main business activity of Pegasus Farmaco (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Pegasus Farmaco (India) Private Limited, buy the company report.
Financials of Pegasus Farmaco (India) Private Limited
FY 2021 filings availablePegasus Farmaco (India) Private Limited reported revenue of ₹33.13 Cr (down 34% YoY) for FY 2021.
Revenue · FY 2021
₹33.13 Cr ▼ 34%
Net profit · FY 2021
₹51.18 Lakh margin 1.5%
EBITDA · FY 2021
₹3.93 Cr margin 11.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 34%
3 years · compounded
▼ 7%
5 years · compounded
▼ 13%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 19%
5 years · compounded
▲ 9%
Revenue has declined at a compounded annual rate (CAGR) of 13% over five years, including a 34% fall in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹33.13 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.93 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹51.18 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.8% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pegasus Farmaco (India) Private Limited, buy the company report.
Board of directors of Pegasus Farmaco (India) Private Limited
Pegasus Farmaco (India) has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neeraja Beti Also directs: Bethi Medikamente Private Limited | Director | 30 Sep 2004 | 22 Years 1 Months | Current |
| Raghuveer Beti | Managing Director | 12 Apr 2004 | 22 Years 6 Months | Current |
Peer comparison
Pegasus Farmaco (India) Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kosher Pharmaceutical Private Limited | ₹33.59 Cr (FY 2020) | 135.0% | Hyderabad, Telangana, India | |||
| Cureza Healthcare Private Limited | ₹33.53 Cr (FY 2025) | 74.0% | Indore, Madhya Pradesh, India | |||
| Stafford Laboratories Private Limited | ₹33.42 Cr (FY 2024) | 14.0% | Kolkata, West Bengal, India | |||
| Pegasus Farmaco (India) Private Limitedthis company | ₹33.13 Cr (FY 2021) | ₹51.18 Lakh | 1.5% | -34.0% | 127 | Hyderabad, Telangana, India |
| Kim Laboratories Pvt Ltd | ₹33.1 Cr (FY 2025) | 4.0% | Haryana, India | |||
| Health Care Formulations Private Limited | ₹33.06 Cr (FY 2023) | 29.0% | Vadodara, Gujarat, India | |||
| Saar Biotech Private Limited | ₹33.04 Cr (FY 2024) | 20.0% | Chandigarh, India |
To see the full peer comparison of Pegasus Farmaco (India) Private Limited, buy the company report.
Shareholding
The shareholding of Pegasus Farmaco (India) Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pegasus Farmaco (India) Private Limited, buy the company report.
Charges & borrowings
Open charges
₹18.06 Cr
Satisfied charges
₹14.79 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Jul 2019 | 100284357 | Others | ₹18.06 Cr | Open | |
| 14 May 2007 | 10057413 | State Bank of India | ₹12.69 Cr | Satisfied | |
| 26 Oct 2005 | 80032538 | Punjab National Bank | ₹1.9 Cr | Satisfied | |
| 07 May 2003 | 90136227 | City Union Bank Ltd. | ₹10 Lakh | Satisfied | |
| 20 Jul 1998 | 90134149 | State Bank of Hyderabad | ₹10 Lakh | Satisfied |
To see the full charge records of Pegasus Farmaco (India) Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Pegasus Farmaco (India) Private Limited has 7 deals on record (3 funding rounds, 2 rights issues, 2 secondary share transfers), with disclosed funding of ₹3.35 Cr; the latest was in January 2019.
Total deals
7
Funding rounds
3
Rights issues
2
Secondary share transfers
2
Disclosed funding
₹3.35 Cr
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2019 | Rights issue | ₹50 Lakh | Investors: 2 individuals |
| Mar 2016 | Rights issue | ₹58 Lakh | Investors: 4 individuals |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: an individual |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
| Mar 2012 | Funding round | ₹1.5 Cr | Investors: 4 individuals |
To see the full deal history of Pegasus Farmaco (India) Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Pegasus Farmaco (India) Private Limited has 38 court cases on record: 3 filed by Pegasus Farmaco (India), 35 filed against it. 19 cases are pending and 19 are disposed.
Total cases
38
Filed by the company
3
Filed against the company
35
Pending
19
Disposed
19
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 27 | 27 | 18 |
| High courts | 8 | 5 | 0 |
| NCLAT | 2 | 2 | 1 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 38)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed against the company by Acg Associated Capsules Pvt Ltd Through Senior Manager Prashant Nambiar | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Kotak Mahindra Bank Ltd | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Iifl Finance Limited | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed against the company by Acg Associated Capsules Pvt Ltd Through Senior Manager Prashant Nambiar | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary case) | Filed against the company by Aarti Drugs Ltd Through Its Authorised Representative Mr Venkatesh Nadar | Pending |
To see the full case history of Pegasus Farmaco (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pegasus Farmaco (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Pegasus Farmaco (India) Private Limited has a workforce of 127 employees on its EPFO records as of Apr 03, 2024, across 1 active EPFO establishment.
Employee count
127
Active EPFO establishments
1
Employee growth
-26.59%
GST
Pegasus Farmaco (India) has 6 GST registrations: 3 active and 3 cancelled or inactive.
Total GSTINs
6
Active
3
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCP2118E1ZW | Telangana | Active | 01 Jul 2017 |
| 05AABCP2118E1Z1 | Uttarakhand | Active | 01 Jul 2017 |
| 19AABCP2118E1ZS | West Bengal | Active | 05 Feb 2020 |
To see the full GST registrations and return filing status of Pegasus Farmaco (India) Private Limited, buy the company report.
Recent activity
Pegasus Farmaco (India) Private Limited has 8 board changes on record since 2004: 5 appointments and 3 cessations. The latest: Vodela Mallikarjun ceased to be Additional Director on 16 Oct 2023.
Ceased
Vodela Mallikarjun ceased to be Additional Director.
Appointed
Vodela Mallikarjun was appointed as Additional Director.
Charges
A charge with Others of Rs. 18.06 Cr registered on 20 Jul 2019 with Charge ID 100284357 was modified on 27 Mar 2023.
Ceased
Vuthoori Indira ceased to be Director.
Ceased
Vuthoori Surender ceased to be Director.
AGM
Pegasus Farmaco (India) Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Filing
Pegasus Farmaco (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad.
Charges
A charge registered on 14 May 2007 via Charge ID 10057413 with State Bank Of India was fully satisfied on 14 Aug 2019.
Charges
A charge with Others amounted to Rs. 18.06 Cr with Charge ID 100284357 was registered on 20 Jul 2019.
Charges
A charge with State Bank Of India of Rs. 12.69 Cr registered on 14 May 2007 with Charge ID 10057413 was modified on 18 Sep 2012.
Charges
A charge registered on 26 Oct 2005 via Charge ID 80032538 with Punjab National Bank was fully satisfied on 13 Jun 2007.
Charges
A charge registered on 07 May 2003 via Charge ID 90136227 with City Union Bank Ltd. was fully satisfied on 06 Jun 2007.
11 earlier events are in the company report.
Frequently asked questions
Pegasus Farmaco (India) is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 October 1995 (31+ years old) and is registered under CIN U24230TG1995PTC022036.
Pegasus Farmaco (India) has 2 current directors:
- Raghuveer Beti - Managing Director
- Neeraja Beti - Director
The latest financial statements of Pegasus Farmaco (India) on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of Pegasus Farmaco (India) is 36AABCP2118E1ZW, registered in Telangana. The company has 6 GST registrations in all, of which 3 are active and 3 are cancelled or inactive. Other active GSTINs include 05AABCP2118E1Z1 (Uttarakhand), 19AABCP2118E1ZS (West Bengal).
The CIN (Corporate Identification Number) of Pegasus Farmaco (India) is U24230TG1995PTC022036. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pegasus Farmaco (India) has 38 court cases on record: 3 filed by the company and 35 filed against it. 19 are pending. Most are in the district courts.
Pegasus Farmaco (India) was incorporated on 18 October 1995, making it 31+ years old. It is registered with the Registrar of Companies, Hyderabad.
Pegasus Farmaco (India) has 7 deals on record (3 funding rounds, 2 rights issues, 2 secondary share transfers), with disclosed funding of ₹3.35 Cr; the latest was in January 2019.
The peers of Pegasus Farmaco (India) by revenue are Kosher Pharmaceutical Private Limited, Cureza Healthcare Private Limited, Stafford Laboratories Private Limited, Kim Laboratories Pvt Ltd, Health Care Formulations Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vodela Mallikarjun ceased to be Additional Director on 16 Oct 2023. Vodela Mallikarjun was appointed as Additional Director on 23 May 2023. Vuthoori Indira ceased to be Director on 04 Mar 2022. Pegasus Farmaco (India) has 8 board changes on record in total.
Yes, Pegasus Farmaco (India) is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0018395).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages